Safety and Efficacy of Partial Splenic Embolization in Telaprevir-based Triple Therapy for Chronic Hepatitis C-Reference-Cited by-同舟云学术

Safety and Efficacy of Partial Splenic Embolization in Telaprevir-based Triple Therapy for Chronic Hepatitis C

Published:2015 Issue:2 Volume:54 Page:119-126
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kondo Chisa¹,Atsukawa Masanori¹,Tsubota Akihito²,Shimada Noritomo³,Abe Hiroshi⁴,Itokawa Norio¹,Nakagawa Ai¹,Fukuda Takeshi⁵,Matsushita Yoko⁵,Nakatsuka Katsuhisa⁵,Kawamoto Chiaki⁵,Iwakiri Katsuhiko¹,Aizawa Yoshio⁴,Sakamoto Choitsu⁵

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Japan

2. Core Research Facilities for Basic Science, Research Center for Medical Sciences, The Jikei University School of Medicine, Japan

3. Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Japan

4. Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine Katsushika Medical Center, Japan

5. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Reference32 articles.

1. 1. Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 19: 850-858, 2013.

2. 2. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671-675, 1990.

3. 3. Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47: 131-136, 2000.

4. 4. Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 315: 1575-1578, 1986.

5. 5. Cardoso AC, Moucari R, Figueiredo-Mendes C, et al. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. J Hepatol 52: 652-657, 2010.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partial splenic embolization with embosphere microspheres (700-900 µm) for the treatment of hypersplenism: comparison of selective superior splenic artery embolization and inferior splenic artery embolization;Minimally Invasive Therapy & Allied Technologies;2024-04-12

2. Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review;Journal of Vascular and Interventional Radiology;2020-07

3. What are the Particularities of Splenic Surgery in Cirrhotic Patients?;Chirurgia;2020

4. Partial Splenic Embolization for Lenvatinib Therapy-associated Thrombocytopenia Among Patients With Hepatocellular Carcinoma;Anticancer Research;2019-12

5. Interventional Radiology: Partial Splenic Embolization;Clinical Investigation of Portal Hypertension;2019